Results 201 to 210 of about 50,269 (316)

Elevated Triglyceride‐Glucose Index Is Associated With Insulin Resistance, Metabolic Syndrome Components, Nonalcoholic Fatty Liver Disease, and Adverse Pregnancy Outcomes in Chinese Women With Polycystic Ovary Syndrome

open access: yesClinical Endocrinology, Volume 103, Issue 3, Page 317-326, September 2025.
ABSTRACT Aim To investigate the associations of triglyceride‐glucose index (TyG) with anthropometric characteristics, metabolic/endocrine profiles, and pregnancy outcomes in Chinese women with polycystic ovary syndrome (PCOS). Methods This secondary analysis of the Acupuncture and Clomiphene for Chinese Women with Polycystic Ovary Syndrome trial ...
Jiaxing Feng   +6 more
wiley   +1 more source

Effectiveness of Open Fenestration for Autosomal Dominant Polycystic Liver Disease. [PDF]

open access: yesCase Rep Gastroenterol, 2022
Norcia LF   +5 more
europepmc   +1 more source

Phenotypic Divergence of JAG1‐ and NOTCH2‐Associated Alagille Syndrome & Disease‐Specific NOTCH2 Variant Classification Guidelines

open access: yesLiver International, Volume 45, Issue 9, September 2025.
ABSTRACT Background & Aims Alagille syndrome (ALGS) is a rare, autosomal dominant disorder with high phenotypic heterogeneity. Disease‐causing variants are primarily identified in Jagged1 (JAG1), with fewer reported in NOTCH2. JAG1 variants cause disease through a mechanism of haploinsufficiency, but the mechanism for NOTCH2 variants is not completely ...
Shannon M. Vandriel   +91 more
wiley   +1 more source

Boy with autosomal recessive polycystic kidney and autosomal dominant polycystic liver disease [PDF]

open access: green, 2012
Andrea Zingg-Schenk   +5 more
openalex   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists Improve MASH and Liver Fibrosis: A Meta‐Analysis of Randomised Controlled Trials

open access: yesLiver International, Volume 45, Issue 9, September 2025.
ABSTRACT Background/Aims There is uncertainty regarding the hepatic efficacy of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) in metabolic dysfunction‐associated steatotic liver disease (MASLD) or steatohepatitis (MASH). We performed a meta‐analysis of randomised controlled trials (RCTs) to examine the efficacy of GLP‐1RAs in treating MASLD or ...
Alessandro Mantovani   +7 more
wiley   +1 more source

A Rare Cause of Cholestasis Related to Polycystic Liver Disease

open access: yesGE: Portuguese Journal of Gastroenterology, 2021
Pedro Costa-Moreira   +2 more
doaj   +1 more source

Co-Occurrence of Neurofibromatosis Type 1 and Polycystic Liver Disease: A Case of Hypertension with PKHD1 Variant. [PDF]

open access: yesAm J Case Rep
Thewjitcharoen Y   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy